Pulmonary Disease Center

Has it been getting harder for you to breathe? Maybe it’s the weather, but it could be COPD.

Knowing your asthma triggers is the first step in avoiding them.

The US Food and Drug Administration (FDA) has approved a generic of a common asthma medication.

There's a new treatment for severe asthma.

When the weather gets cold, a lot of people who have asthma notice that their symptoms get worse. Why does this happen, and how can you avoid it?

The US Food and Drug Administration (FDA) has approved a new inhaler for COPD.

The US Food and Drug Administration (FDA) has approved the strongest possible warning for a common asthma medication.

The US Food and Drug Administration (FDA) has approved the first generic version of a common asthma inhaler.

The US Food and Drug Administration (FDA) is requiring a stronger warning for a common asthma medication.

The US Food and Drug Administration (FDA) has approved the first generic version of a common asthma inhaler.

Has it been getting harder for you to breathe? Maybe it’s the weather, but it could be COPD.

An asthma medication that once could only be given at a doctor's office can now be given at home.

In the United States, an estimated 15.4 million people are treated for asthma each year. This places an enormous burden on both individual patients and the US economy.

The US Food and Drug Administration (FDA) has approved the first generic Advair Diskus to treat asthma and chronic obstructive pulmonary disease (COPD).

The US Food and Drug Administration (FDA) has approved the only asthma inhaler available over the counter (OTC) in the United States.

The US Food and Drug Administration (FDA) has approved a new device to treat breathing trouble tied to severe emphysema.

Although asthma attacks have declined among children in the US, the Centers for Disease Control and Prevention (CDC) said there is still work to be done.

The US Food and Drug Administration (FDA) has removed a strong warning for some combination inhalers.

The US Food and Drug Administration (FDA) has approved the first drug to treat a rare condition that causes inflammation in the wall of the body's blood vessels.

In recent decades, the United States has seen an increase in deaths from chronic respiratory diseases, according to a new study.